Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 32Breast Neoplasms 21Neoplasms 16Prostatic Neoplasms 11Obesity 8Sarcopenia 6Colorectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Head and Neck Neoplasms 5Polycystic Ovary Syndrome 4Signs and Symptoms 3Multiple Myeloma 3Lymphedema 3Inflammation 3Fatigue 3Diabetes Mellitus, Type 2 3Colonic Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Overweight 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia 2Laryngeal Neoplasms 2Insulin Resistance 2Hematopoietic and Lymphatic System Neoplasm 2Endometrial Neoplasms 2

Interventions

Exercise 3Metformin 2Megestrol Acetate 2Yoga 1Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Professional Autonomy 1Prebiotics 1Nutrition Assessment 1Motivational Interviewing 1Mirtazapine 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Doxorubicin 1Dietary Supplements 1Diet Therapy 1Diet 1Cyclophosphamide 1Cisplatin 1Caseins 1Caloric Restriction 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Body Weight × Resistance Training × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡